Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

12.28
Delayed Data
As of Aug 18
 -0.23 / -1.84%
Today’s Change
8.67
Today|||52-Week Range
14.55
+14.77%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close12.51
Today’s open12.42
Day’s range12.25 - 12.55
Volume713,670
Average volume (3 months)952,843
Market cap$1.3B
Dividend yield7.91%
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+119.25%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+117.48%
P/E ratio15.0
Price/Sales8.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+0.50+2.79%
MYOKMyoKardia Inc-3.13-7.18%
EBSEmergent BioSolution...-0.67-1.89%
PCRXPacira Pharmaceutica...-0.25-0.69%
Data as of 4:02pm ET, 08/18/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$0.32
Annual revenue (last year)$147.4M
Annual profit (last year)$59.5M
Net profit margin40.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
Brisbane, California

Forecasts